Ozempic is under clinical development by Novo Nordisk and currently in Phase III for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD).

Peripheral artery disease (PAD) is a condition where the arteries in your limbs, most commonly the legs, become narrowed, ...

Peripheral artery disease is a common circulatory problem in which narrowed arteries reduce blood flow to the limbs. PAD primarily affects the legs, but it can also damage arteries in the head, arms, ...

Healthcare experts at Abbott, which has spearheaded the campaign, say that 80% of diabetes amputations are preventable ...

One major culprit is peripheral artery disease, a recurring buildup of plaque in the arteries that limits blood flow to the legs and feet. If not identified and managed properly, "PAD can lead to ...

Peripheral Artery Disease (PAD) is characterized by narrowed peripheral arteries, often due to atherosclerosis. Symptoms include leg pain, numbness, and slow-healing sores. Management involves ...

The clot-sensing technology can be incorporated into devices such as catheters and guidewires for PAD treatments.

Add-on therapy with SGLT2 inhibitors, compared with DPP-4 inhibitors, was associated with an increased risk for peripheral ...

During a 25-year period ending in 2022, public health officials in 23 states — including New York — and Puerto Rico reported 60 "splash pad" associated outbreaks due to waterborne disease ...

Sensome today announced positive results from two studies of its Clotlid smart guidewire system for identifying blood clots.